| Patents for C12N 9 - Enzymes, e.g. ligases (6.); Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating, or purifying enzymes (141,535) |
|---|
| 04/01/2004 | WO2003095670A3 Process for generating sequence-specific proteases by directed evolution and use thereof |
| 04/01/2004 | WO2003084566A3 Proteins involved in the regulation of energy homeostasis |
| 04/01/2004 | WO2003084540A3 Compositions comprising mmp7 modulators for the treatment of chronic pain |
| 04/01/2004 | WO2003082911A3 Use of the protein maba (fabg1) of mycobacterium tuberculosis for designing and screening antibiotics |
| 04/01/2004 | WO2003077868A3 Synthesis of synthons for the manufacture of bioactive compounds |
| 04/01/2004 | WO2003075834A3 Activated protein c formulations |
| 04/01/2004 | WO2003074078A3 Cg3842 homologous proteins involved in the regulation of energy homeostasis |
| 04/01/2004 | WO2003070907A3 Novel fungal lipase |
| 04/01/2004 | WO2003060100A3 CRYSTALLIZED DnaG PRIMASE COMPLEXES AND METHODS OF USE THEREOF |
| 04/01/2004 | WO2003057841A8 Remote homologues and kinases and methods of detection |
| 04/01/2004 | WO2003040180A3 Genes of corynebacterium glutamicum encoding for genetic stability, gene expression and folding proteins |
| 04/01/2004 | WO2003020885A9 Identification of sortase gene |
| 04/01/2004 | WO2003016492A3 Adamts13 genes and proteins and variants, and uses thereof |
| 04/01/2004 | WO2003012065A3 Kinases and phosphatases |
| 04/01/2004 | WO2003008440A3 Nucleic acid molecules encoding proteins essential for plant growth |
| 04/01/2004 | WO2002077180A3 Novel nucleic acids and polypeptides |
| 04/01/2004 | WO2002072006A9 METHODS AND REAGENTS FOR IDENTIFYING COMPOUNDS AND MUTATIONS THAT MODULATE DOPAMINE β-HYDROXYLASE ACTIVITY |
| 04/01/2004 | WO2002070676A9 Use of protein histidine phosphatase |
| 04/01/2004 | US20040064857 Using agrobacterium to generate transgenic sterility controllable plant model for monitoring heterologous gene expression; tissue engineering |
| 04/01/2004 | US20040064856 Regulatory sequences for controlling heterologous gene expression in plants; tissue engineering |
| 04/01/2004 | US20040064855 Production of lysosomal enzymes in plants by transient expression |
| 04/01/2004 | US20040064848 Comprises nucleotide sequences coding dehydroquinase/shikimate dehydrogenase for use in high throughput assay which detects herbicides |
| 04/01/2004 | US20040064842 Using dispersed regulatory nucleotide sequences to regulate transcription in animal cells, tissues and/or organs; gene expression inhibition |
| 04/01/2004 | US20040063921 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 04/01/2004 | US20040063909 Comprises nucleotide sequences coding membrane proteins for treatment and diagnosis cell proliferative, inflammatory, autoimmune and nervous system disorders |
| 04/01/2004 | US20040063908 Comprises genetically engineered hemophilus adherence and penetration (HAP) proteins for treatment and prevention of influenza; immunotherapy |
| 04/01/2004 | US20040063902 Decomposition of immobilized polypeptide |
| 04/01/2004 | US20040063790 By administering an organic peptidomimetic vibronectin receptor alpha v beta 3 antagonist of given structures |
| 04/01/2004 | US20040063652 Introducing multiple nucleic acid molecules simultaneously without deletereous effects; controlling level of expression |
| 04/01/2004 | US20040063617 Expressing a nucleic acid encoding protein selected from lactoferrin protein and lysozyme protein in a monocot seed; isolating protein from the seed, combining with carrier diluent to provide formulation for oral administration |
| 04/01/2004 | US20040063207 Recombinational cloning using nucleic acids having recombination sites |
| 04/01/2004 | US20040063187 Process for the preparation in pure form of the protease activating blood clotting factor VII, its proenzyme or a mixture of both proteins by means of chromatography |
| 04/01/2004 | US20040063184 Using transgenic yeast to generate ethanol and esterases |
| 04/01/2004 | US20040063182 Process for producing prenyl alcohol |
| 04/01/2004 | US20040063181 Process for the preparation of L-amino acids using a gene encoding 6-phosphogluconate dehydrogenase |
| 04/01/2004 | US20040063180 Comprises nucleotide sequences coding lysine biosynthetic polypeptide for transforming coryneform bacteria and fermentation of lysine; animal feeds and medicine |
| 04/01/2004 | US20040063178 Comprises enzymatic polypeptide for identifying modulators of leukocyte adhesion and treatments of inflammatory diseases l |
| 04/01/2004 | US20040063177 Generating subtilisin mutant with decreased immunogenicity for use in laundry detergents, cosmetics and textile treatment |
| 04/01/2004 | US20040063175 Transgenic cell for preparation of monatin; food and beverage sweetening |
| 04/01/2004 | US20040063174 Comprises nucleotide sequences coding allelic cyclase for identifying modulators which prevent, ameliorate or correct dysfunction or diseases of central nervous and urogenital systems |
| 04/01/2004 | US20040063166 Using transgenic eschrichia to prepare biotin via fermentation from nutrient broth containing desthiobiotin; medicines and food additives |
| 04/01/2004 | US20040063161 Compositions and method of treating Alzheimer's disease |
| 04/01/2004 | US20040063155 Using subtilisin to target preferential nucleotide sequences and diagnose viral and parasitic infections |
| 04/01/2004 | US20040063143 Comprises nucleotide sequences coding enzymatic polypeptides associated with steroid, carotenoids and squalene biosynthesis |
| 04/01/2004 | US20040063142 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins and uses thereof |
| 04/01/2004 | US20040063135 Comprises oligonucleotides for determining concentration of glucuonidase in cell culture; detection and monitoring of malignancies and metastasis; targeted drug delivery |
| 04/01/2004 | US20040063130 Comprises tyrosine kinase peptides for identifying modulators for treatment of inflammation, cancer, arteriosclerosis and psoriasis |
| 04/01/2004 | US20040063116 Genetically engineered pancreatic-protease for identifying malarial plasmepsin II and treating parasitic infection |
| 04/01/2004 | US20040063115 Comprises catalyst polypeptides for diagnosis, prevention and treatment of cell proliferative, autoimmune, inflammatory, cardiovascular, gastrointestinal, neurological, respiratory, sexual vision disorders |
| 04/01/2004 | US20040063107 Novel proteases |
| 04/01/2004 | US20040062777 Genetic engineered polypeptides; enzyme inhibitors |
| 04/01/2004 | US20040062761 Nucleic acid and corresponding protein entitled 151P3D4 useful in treatment and detection of cancer |
| 04/01/2004 | US20040062760 Human complement C3-binding protein from streptococcus pneumoniae |
| 04/01/2004 | US20040062748 Complex of active material and polyoxyethylene glycol |
| 04/01/2004 | US20040062746 Polymer conjugates with decreased antigenicity, methods of preparation and uses thereof |
| 04/01/2004 | DE10244842A1 Für proteinspaltende Enzyme in Form von spezifischen Proteasen kodierende Nukleinsäuresequenzen, zugehörige Polypeptide und Verwendung von allen For protein-splitting enzymes in the form of specific proteases coding nucleic acid sequences associated polypeptides and use of all |
| 04/01/2004 | CA2695720A1 Method of producing epothilone b by culturing sorangium cellulosum in a medium comprising propionic acid |
| 04/01/2004 | CA2695671A1 Methods for the preparation, isolation and purification of epothilone b, and x-ray crystal structures of epothilone b |
| 04/01/2004 | CA2499467A1 Methods for increasing the production of a recombinant polypeptide from a host cell |
| 04/01/2004 | CA2497560A1 Luminescence-based methods and probes for measuring cytochrome p450 activity |
| 04/01/2004 | CA2497434A1 Inducible focal adhesion kinase cell assay |
| 04/01/2004 | CA2496300A1 Transgenic expression cassettes for the expression of nucleic acids in plant blooms |
| 04/01/2004 | CA2486280A1 Identification of a phage associated lytic enzyme to rapidly and specifically detect and kill bacillus anthracis |
| 03/31/2004 | EP1403643A1 Lawsonia intracellularis cultivation, anti-lawsonia intracelluaris vaccines and diagnostic agents |
| 03/31/2004 | EP1403377A1 Consensus phytases |
| 03/31/2004 | EP1403373A1 Saponin-digesting enzymes, genes thereof and soyasapogenol b mass production system |
| 03/31/2004 | EP1403372A2 Composition and methods for the treatment and diagnosis of cardiovascular disease |
| 03/31/2004 | EP1403364A1 Mutant rna polymerases |
| 03/31/2004 | EP1403283A1 Tumor antigen |
| 03/31/2004 | EP1402267A1 Chp for use as marker for sepsis-type inflammatory diseases |
| 03/31/2004 | EP1402260A2 Ns4 nucleic acids and polypeptides and methods of use for the treatment of body weight disorders |
| 03/31/2004 | EP1402256A2 P-cadherin as a target for anti-cancer therapy |
| 03/31/2004 | EP1402109A2 Use of lipolytic enzymes for stickies control |
| 03/31/2004 | EP1402049A2 Production of high levels of transgenic factor viii with engineered stability, and its therapeutic uses |
| 03/31/2004 | EP1402048A2 Methods of 6-o-sulfating polysaccharides and 6-o-sulfated polysaccharide preparations |
| 03/31/2004 | EP1402042A2 Abiotic stress responsive polynucleotides and polypeptides |
| 03/31/2004 | EP1402040A2 A novel intein and uses thereof |
| 03/31/2004 | EP1402038A2 Identification and characterization of plant genes |
| 03/31/2004 | EP1402036A2 Expression vectors encoding bacteriophage signal peptides |
| 03/31/2004 | EP1402027A2 Human methyltransferase family member, 25552, and uses thereof |
| 03/31/2004 | EP1402026A2 39228, a human alcohol dehydrogenase and uses therefor |
| 03/31/2004 | EP1402022A2 Use of a tyrosine recombinase for genetic engineering |
| 03/31/2004 | EP1402020A2 Methods, vectors, cell lines and kits for selecting nucleic acids having a desired feature |
| 03/31/2004 | EP1402015A2 A soluble complex comprising a retroviral surface glycoprotein |
| 03/31/2004 | EP1402014A1 A process for purification of recombinant porphobilinogen deaminase |
| 03/31/2004 | EP1402013A2 Homoaconitase as a target for fungicides |
| 03/31/2004 | EP1402012A2 Methods of using 18903 to treat pain and pain-related disorders |
| 03/31/2004 | EP1402011A2 Proteins in a porous support |
| 03/31/2004 | EP1402010A2 8843, a human dual specificity phosphatase family member and uses therefor |
| 03/31/2004 | EP1402009A1 Novel mixed lineage kinase (7) (mlk7) polypeptide, polynucleotides encoding the same, and methods of use thereof |
| 03/31/2004 | EP1402008A2 Method for purifying an enzyme, a purified enzyme produced thereby, and use of this enzyme |
| 03/31/2004 | EP1402007A1 Bcl-2 dnazymes |
| 03/31/2004 | EP1401867A2 Mycobacterial antigens expressed under low oxygen tension |
| 03/31/2004 | EP1401804A1 Catalase inactivating compounds and their use |
| 03/31/2004 | EP1401468A2 Induction of blood vessel formation through administration of polynucleotides encoding sphingosine kinases |
| 03/31/2004 | EP1401461A2 Selective cox-2 inhibition from edible plant extracts |
| 03/31/2004 | EP1401453A2 Protease inhibitors |
| 03/31/2004 | EP1401412A2 Use of potent, selective and non toxic c-kit inhibitors for treating tumor angiogenesis |
| 03/31/2004 | EP1401411A2 Use of tyrosine kinase inhibitors for treating bone loss |
| 03/31/2004 | EP1401383A2 Use of at least an oil extracted from the seeds of the gourd family for preparing a composition for inhibiting 5-alpha-reductase activity |